Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Dose Comparison for Prevention of Chronic Postsurgical Pain After Scoliosis Surgery
NCT06087510Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in chronic postsurgical pain (CPSP) (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of chronic postsurgical pain at 3 months. Started Jan 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT06087510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087510.